Comparing the average enrichment of the two EGFR mutated patients with the remaining EGFR‐WT NSCLC patients (n = 6) revealed that EGFR is the most enriched gene in EGFR‐mutated patients (Fig. 3C; Table S8). This evidence concerns the gene EGFR and non-small cell lung carcinoma.